Hematology/Oncology Associates

Lake Worth, Florida 33461-4710

0 studies enrolling now · 11 studies all time

What they study most

Breast Cancer, Breast Neoplasms, Cachexia, Cancer, Colonic Neoplasms, Colorectal Neoplasms, Gastrointestinal Stromal Tumor, Idiopathic Thrombocytopenic Purpura, Metastatic Pancreatic Cancer, Neoplasm Metastasis, Ovarian Cancer, Pain

Studies at this site

• A Study Comparing Eribulin Mesylate and Ixabepilone in Causing or Exacerbating Neuropathy in Participants With Advanced Breast Cancer — Completed
• Efficacy and Safety of Farletuzumab (MORAb-003) in Combination With Carboplatin and Taxane in Participants With Platinum-sensitive Ovarian Cancer in First Relapse — Stopped early
• Weekly vs. Every 2 Week vs. Every 3 Week Administration of ABI-007 (Abraxane)/Bevacizumab Combination in Metastatic Breast Cancer — Stopped early
• IGIV Study for Chronic ITP Patients Ages 3-70 — Completed
• Study of Oxaliplatin/5-FU/Leucovorin Plus Vatalanib Versus Oxaliplatin/5-FU/Leucovorin in Patients With Previously Treated Metastatic Colorectal Cancer — Completed
• Study of CR011-vcMMAE to Treat Locally Advanced or Metastatic Breast Cancer — Completed
• Comparison of Two Different Doses of STI571 in Treating Patients With Metastatic or Unresectable Gastrointestinal Stromal Tumor — Stopped early
• Study of GTx-024 on Muscle Wasting (Cachexia) Cancer. — Completed
• APRiCOT-P: Study of Apricoxib With Gemcitabine and Erlotinib to Treat Advanced Pancreatic Cancer — Completed
• OraVescent Fentanyl (OVF) for the Treatment of Breakthrough Pain in Opioid Tolerant Cancer Patients — Completed
• APRiCOT-B: Study to Evaluate Apricoxib in Combination With Lapatinib and Capecitabine in the Treatment of HER2/Neu+ Breast Cancer (TP2001-202) — Stopped early